Vernal Biosciences
United States
- Burlington , VT
- 02/06/2022
- Seed
- $21,000,000
Vernal Biosciences is a CDMO democratizing the use of mRNA through a quality-first approach to manufacturing mRNA for all purposes.
- Industry Biotechnology
- Website https://www.vernal.bio/
- LinkedIn https://www.linkedin.com/company/vernal-biosciences/
Related People
Christian CobaughFounder
United States -
Cambridge, Massachusetts,
Experienced in LNP-mRNA process technologies, manufacturing, quality, and regulatory interactions.
Leadership in pre-clinical research for candidate selection & non-clinical development across many therapeutic platforms. Able to identify targets and discovery cascades in various therapeutic areas and organ systems. Skilled at identifying external drug, technology, and platform assets. Accomplished at designing experimental cascades, building and leading teams of scientists & stakeholders to drive early stage discovery to clinical endpoints. Versatile scientific manager, able to identify essential questions to streamline R&D geared for commercial and intellectual property success.
Specialties:
Assay development for gene editing, cellular & in vivo pharmacology, process development & CMC
RNA, gene editing (CRISPR/Cas, TALENS), small molecule, & monoclonal antibodies therapeutics
R&D: drug discovery, IND-enabling, & platform development
Target concept ID to first-in-human
Research externalization, CRO & academic management
Molecular engineering of therapeutic proteins and mRNA
Phage display and protein engineering
Development of discovery cascades & novel screening technologies
Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)